Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Allatotropin secretion machinery is a complex biological system in insects responsible for the synthesis, transport, and release of the neuropeptide Allatotropin (AT) (Diab et al., 2023; Kataoka et al., 1989). AT is a pleiotropic hormone primarily known for its role in stimulating the corpora allata to produce juvenile hormone (JH), which is essential for regulating insect development, metamorphosis, and reproduction (Horodyski, 2013). The secretion machinery involves a coordinated network of proteins, including Rab GTPases (such as RabX4 and Rab1) that manage vesicle trafficking, and SNARE proteins (like Syntaxin 1A and SNAP-25) that facilitate the fusion of secretory vesicles with the plasma membrane at neurohemal release sites (Diab et al., 2023; Schoofs et al., 2017). Beyond JH regulation, the machinery supports AT's roles in modulating gut motility, heart rate, and circadian rhythms (Horodyski, 2013). Due to its central role in insect physiology, components of the Allatotropin secretion machinery are considered promising targets for the development of highly specific bioinsecticides, often utilizing RNA interference (RNAi) to disrupt the life cycle of agricultural pests and disease vectors (Down & Audsley, 2022). Research has shown that silencing specific Rab proteins can significantly reduce the secretion of allatotropic factors, leading to developmental arrest (Diab et al., 2023). This makes the machinery a focal point for biotechnology companies aiming to create environmentally friendly alternatives to broad-spectrum chemical pesticides.
Inhibition of neuropeptide secretion via disruption of vesicle trafficking or membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allatotropin secretion machinery.